What is OnKure Therapeutics, Inc.'s net income?

OnKure Therapeutics, Inc. (OKUR) reported net income of -$15.16M in Q1 2026.

How has OnKure Therapeutics, Inc.'s net income changed year-over-year?

OnKure Therapeutics, Inc.'s net income increased by 4.8% year-over-year, from -$15.93M to -$15.16M.

What is the long-term trend for OnKure Therapeutics, Inc.'s net income?

Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s net income has grown at a 14.4% compound annual growth rate (CAGR), from -$39.77M to -$59.52M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

OnKure Therapeutics, Inc. OKUR Net Income

Net Income at other companies

PfizerPFE

$2.7B-9.3%

Eikon Therapeutics, Inc. EIKN

-$82.96M-21.6%

Inhibrx Biosciences, Inc.INBX

-$33.44M+22.8%

Replimune GroupREPL

-$70.93M-6.9%

IDEAYA Biosciences, Inc.IDYA

-$98.54M-36.5%

Erasca, Inc.ERAS

-$183.44M-492%

Segments

By segment

See full

Clinical Research-$15.62M+8.1%

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Return on equity-42.7%—

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s net income?: OnKure Therapeutics, Inc. (OKUR) reported net income of -$15.16M in Q1 2026.
How has OnKure Therapeutics, Inc.'s net income changed year-over-year?: OnKure Therapeutics, Inc.'s net income increased by 4.8% year-over-year, from -$15.93M to -$15.16M.
What is the long-term trend for OnKure Therapeutics, Inc.'s net income?: Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s net income has grown at a 14.4% compound annual growth rate (CAGR), from -$39.77M to -$59.52M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.